Rieckmann P - Search Results

1

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group (MSTCG), et al. Among authors: rieckmann p. J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29. J Neurol. 2008. PMID: 19005625

2

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H. Brück W, et al. Among authors: rieckmann p. Ann Neurol. 1995 Nov;38(5):788-96. doi: 10.1002/ana.410380514. Ann Neurol. 1995. PMID: 7486871

3

[Pathogenesis and therapy of multiple sclerosis. The role of cytokines].

Weber F, Rieckmann P. Weber F, et al. Among authors: rieckmann p. Nervenarzt. 1995 Feb;66(2):150-5. Nervenarzt. 1995. PMID: 7715757 Review. German.

4

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Helwig A, Poser S. Rieckmann P, et al. Ann Neurol. 1995 Jan;37(1):82-8. doi: 10.1002/ana.410370115. Ann Neurol. 1995. PMID: 7818262

5

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis.

Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Poser S. Rieckmann P, et al. Neurology. 1994 Aug;44(8):1523-6. doi: 10.1212/wnl.44.8.1523. Neurology. 1994. PMID: 8058164

6

The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosis.

Rieckmann P, Weber F, Günther A, Poser S. Rieckmann P, et al. Neurology. 1996 Aug;47(2):604. doi: 10.1212/wnl.47.2.604. Neurology. 1996. PMID: 8757052 No abstract available.

7

Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.

Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P. Braun N, et al. Among authors: rieckmann p. Neurosci Lett. 1996 Sep 6;215(2):75-8. Neurosci Lett. 1996. PMID: 8887999

8

Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.

Rieckmann P, Altenhofen B, Riegel A, Baudewig J, Felgenhauer K. Rieckmann P, et al. Ann Neurol. 1997 Mar;41(3):326-33. doi: 10.1002/ana.410410307. Ann Neurol. 1997. PMID: 9066353 Clinical Trial.

9

Pathogenesis of immune-mediated demyelination in the CNS.

Hartung HP, Rieckmann P. Hartung HP, et al. Among authors: rieckmann p. J Neural Transm Suppl. 1997;50:173-81. doi: 10.1007/978-3-7091-6842-4_17. J Neural Transm Suppl. 1997. PMID: 9120417 Review.

10

Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood.

Kruse N, Pette M, Toyka K, Rieckmann P. Kruse N, et al. Among authors: rieckmann p. J Immunol Methods. 1997 Dec 29;210(2):195-203. doi: 10.1016/s0022-1759(97)00188-9. J Immunol Methods. 1997. PMID: 9520302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters